Faculty Bibliography

OBJECTIVE: The purpose of this study is to compare the diagnostic accuracy of liver apparent diffusion coefficient (ADC) versus normalized liver ADC using the spleen as a reference organ for the diagnosis of liver fibrosis and cirrhosis. MATERIALS AND METHODS: Fifty-six patients, 34 with liver disease and 22 control subjects, were assessed with breath-hold single-shot echo-planar diffusion-weighted imaging using b values of 0, 50, and 500 s/mm(2). Liver ADC and normalized liver ADC (defined as the ratio of liver ADC to spleen ADC) were compared between patients stratified by fibrosis stage. Receiver operating characteristic (ROC) analysis was used to determine the performance of ADC and normalized liver ADC for prediction of liver fibrosis and cirrhosis. Reproducibility was assessed by measuring coefficient of variation (n = 7). RESULTS: Liver ADC failed to distinguish individual stages of fibrosis, except between stages 0 and 4. There were significant differences in normalized liver ADC between control livers and intermediate stages of fibrosis (stages 2-3) and cirrhosis (stage 4) and between stages 1 and 4, and there was a trend toward significance between stages 0 and 1 (p = 0.051) and stages 1 and 3 (p = 0.06). ROC analysis showed that normalized liver ADC was superior to liver ADC for detection of stage >/= 2 (area under the ROC curve, 0.864 vs 0.655; p = 0.013) and stage >/=3 (0.805 vs 0.689; p = 0.015), without a difference for diagnosing cirrhosis (0.935 vs 0.720; p = 0.185). Normalized liver ADC had higher reproducibility than ADC (mean coefficient of variation, 3.5% vs 12.6%). CONCLUSION: Our results suggest that normalizing liver ADC with spleen ADC improves diagnostic accuracy for detection of liver fibrosis and cirrhosis when using breath-hold diffusion-weighted imaging, with better reproducibility

Endovascular repair is increasingly considered a less-invasive alternative to open repair of abdominal aortic aneurysm. However, there are still many potential complications of endovascular repair, including endoleaks, graft migration, thrombosis, and fistula formation. Endoleak is the most common complication for which these patients undergo long-term imaging surveillance. Most centers acquire computed tomographic (CT) data before contrast administration and during an arterial and delayed phase of aortic enhancement after the administration of intravenous contrast material to optimize detection of endoleaks. Although this technique works well, the downside is significant patient radiation exposure. Although the carcinogenic risk of ionizing radiation because of CT exposure is low, it has been linked to an increase in the lifelong risk of developing fatal cancers. Furthermore, this risk is cumulative and increases with multiple radiation exposure, as is true in surveillance after endovascular repair. As a result, considerable research is being performed to optimize CT protocols in an effort to decrease radiation dose. One such approach is to image these patients with recently introduced dual source dual-energy CT system. Using this technique, virtual noncontrast data may be generated from a postcontrast acquisition which may obviate the routine acquisition of noncontrast acquisition, thus decreasing radiation dose. In this article, we discuss the role of dual energy CT imaging in evaluation of patients after endovascular repair of abdominal aortic aneurysm

Liver metastases are the most frequently encountered malignant liver lesions in the Western countries. Accurate diagnosis of liver metastases is essential for appropriate management of these patients. Multiple imaging modalities, including ultrasound, CT, positron emission tomography, and MRI, are available for the evaluation of patients with suspected or known liver metastases. Contrast-enhanced MRI has a high accuracy for detection and characterization of liver lesions. Additionally, diffusion-weighted MRI (DWI) has been gaining increasing attention. It is a noncontrast technique that is easy to perform, could be incorporated in routine clinical protocols, and has the potential to provide tissue characterization. This article discusses the basic principles of DWI and discusses its emerging role in the detection of liver metastases in patients with extrahepatic malignancies

PURPOSE: To determine whether liver metastases conspicuity is improved at 80 kVp when compared with weighted average (WA) simulated 120 kVp data using dual source dual energy CT. METHODS: A total of 11 patients with 44 hypo-vascular liver metastases underwent contrast enhanced Dual Energy CT (DECT). In all cases the subject's abdominal diameter measured <or=35 cm. Data were reconstructed as a WA of the 140 kVp and 80 kVp acquisitions (simulating 120 kVp) and as a pure 80 kVp data set. A region of interest cursor was placed within the metastasis and adjacent normal parenchyma and attenuation differences and contrast to noise ratios (CNR) were calculated for the metastases at 80 kVp and on the WA acquisition. A mixed model 2-way analysis of variance was used to test whether the attenuation difference between metastases and normal liver was higher at 80 kVp than 120 kVp. An exact Wilcoxon matched-pairs signed rank test was used to test whether CNR was higher at 80 kVp. Cases were retrospectively reviewed to determine whether lesions could be seen on only one or both data sets. As the 80 kVp tube has a smaller detector than the 140 kVp tube, we also noted whether any of the liver lesions were not included on the 80 kVp dataset. Two radiologists in consensus evaluated the 80 kVp data and WA data and subjectively rated hepatic metastases conspicuity on a 4 point scale; with 1 being excellent, 2 good, 3 poor, and 4 not seen. RESULTS: The mean size of the metastases was 2.6 cm. The mean +/- SD of the attenuation difference between the metastases and the normal liver was 78.37 +/- 24.6 at 80 kVp and 56.89 +/- 17.9 at 120 kVp. The mean difference in attenuation was significantly higher at 80 kVp (P < 0.001). In 2 cases, a metastases was only seen at 80 kVp. The difference between 80 and 120 kVp in terms of CNR was statistically significant (P = 0.042). In one patient, 11 lesions were not included in the smaller field of view of the 80 kVp detector. The conspicuity scores were rated as significantly better at 80 kv than at 120 kVp (P < 0.0001). CONCLUSION: When compared with 120 kVp data, pure 80 kVp data acquired from a dual source dual energy MDCT scanner demonstrates greater attenuation differences and improved contrast to noise between metastatic disease and normal liver

Cardiac computed tomography angiography (CCTA) has emerged as a powerful noninvasive technique for anatomic evaluation of the coronary arteries. Multiple studies have demonstrated very good diagnostic accuracy for detection of coronary artery disease, particularly with 64-slice systems. CCTA allows for accurate assessment of myocardial structure, perfusion, and function comparable to established techniques. CCTA has the potential to be a ''one-stop shop'' because it can be used to assess coronary artery anatomy and myocardial structure, perfusion, and function. In this article, established and emerging CCTA techniques for the evaluation of myocardial structure, perfusion, and function are reviewed

OBJECTIVE: The full diagnostic value of diffusion-weighted (DW) MRI in the evaluation of liver metastases remains uncertain. The aim of the present study was to assess the diagnostic accuracy of DW-MRI and contrast-enhanced MRI (CE-MRI) using extracellular gadolinium chelates, with the reference standard established by consensus interpretation of confirmatory imaging and histopathologic data. METHODS: MR examinations of 51 patients with extrahepatic malignancies were retrospectively reviewed by two independent observers who assessed DW-MRI and CE-MRI for detection of liver metastases. RESULTS: By reference standard, 93 liver lesions (49 metastases and 44 benign lesions) were identified in 27 patients, 11 patients had no liver lesions, and 13 patients had innumerable metastatic and/or benign lesions. There was no difference in diagnostic performance between the two methods for either observer for the diagnosis of metastatic lesions per patient. For per-lesion analysis, sensitivity of DW-MRI was equivalent to CE-MRI for observer 1 (67.3% vs. 63.3%, p = 0.67), but lower for observer 2 (65.3% vs. 83.7%, p = 0.007). By pooling data from both observers, the sensitivity of DW-MRI was 66.3% (65/98) and 73.5% (72/98) for CE-MRI, with no significant difference (p = 0.171). CONCLUSION: DW-MRI is a reasonable alternative to CE-MRI for the detection of liver metastases

Purpose: To investigate whether variability in reported renal apparent diffusion coefficient (ADC) values in literature can be explained by the use of different diffusion weightings (b values) and the use of a monoexponential model to calculate ADC. Materials and Methods: This prospective study was approved by institutional review board and was HIPAA-compliant, and all subjects gave written informed consent. Diffusion-weighted (DW) imaging of the kidneys was performed in three healthy volunteers to generate reference diffusion decay curves. In a literature meta-analysis, the authors resampled the reference curves at the various b values used in 19 published studies of normal kidneys (reported ADC = [2.0-4.1] x 10(-3) mm(2) / sec for cortex and [1.9-5.1] x 10(-3) mm(2) / sec for medulla) and then fitted the resampled signals by monoexponential model to produce 'predicted' ADC. Correlation plots were used to compare the predicted ADC values with the published values obtained with the same b values. Results: Significant correlation was found between the reported and predicted ADC values for whole renal parenchyma (R(2) = 0.50, P = .002), cortex (R(2) = 0.87, P = .0002), and medulla (R(2) = 0.61, P = .0129), indicating that most of the variability in reported ADC values arises from limitations of a monoexponential model and use of different b values. Conclusion: The use of a monoexponential function for DW imaging analysis and variably sampled diffusion weighting plays a substantial role in causing the variability in ADC of healthy kidneys. For maximum reliability in renal apparent diffusion coefficient quantification, data for monoexponential analysis should be acquired at a fixed set of b values or a biexponential model should be used. (c) RSNA, 2010

Purpose: Renal angiomyolipoma (AML) is a benign neoplasm with a propensity to bleed proportional to tumor size. Transarterial embolization prevents hemorrhage by decreasing the angiogenic component of AML. We sought to determine whether baseline vascularity and lipid content of AML measured by MRI techniques can predict embolization response, as measured by changes in volume and vascularity on MRI. Materials and Methods: A retrospective review using an electronic database, over a consecutive 3 year period, identified 38 AMLs that underwent embolization in 22 patients. 15 AMLs had both preembolization and postembolization MRIs. 11 AMLs were in females, 4 in males. Median age was 29 years, range 21-73 years. 13 AMLs occurred in the setting of tuberous sclerosis (TS), and 2 occurred sporadically. Mean interval between baseline MRI and embolization was 86 days (range 7, 324), and mean interval between embolization and follow-up MRI was 331 days (range 35, 876). Baseline vascularity was measured by percent enhancement, with higher enhancement signifying higher vascularity. Baseline lipid content was measured by AML to psoas signal ratio on T1 fat saturation images, with a higher ratio signifying lower lipid content. Response characteristics were percent change in volume and percent change in enhancement. Results: No correlation was seen between change in volume and change in enhancement (R=0.104). Embolization resulted in a mean change in volume of -28% (range -82,+10), and a mean change in enhancement of -41% (range -97,+17). Poor correlations were seen between baseline enhancement and change in volume (R=-0.033), and between baseline enhancement and change in enhancement (R=-0.345). Moderately good correlations were seen between baseline lipid content and change in volume (R=0.625), and between baseline lipid content and change in enhancement (R=0.463). Conclusion: Embolization is effective in decreasing AML size and vascularity, which can be regarded as independent MRI markers of response. Lower baseline lipid content on MRI may predict greater response to embolization. No significant correlation was detected between baseline vascularity and response

Polycystic kidney disease (PKD) is a disorder characterized by the growth of numerous fluid filled cysts in the kidneys. Measuring cystic kidney volume is thus crucial to monitoring the evolution of the disease. While T2-weighted MRI delineates the organ, automatic segmentation is very difficult due to highly variable shape and image contrast. The interactive stereology methods used currently involve a compromise between segmentation accuracy and time. We have investigated semi-automated methods: active contours and a sub-voxel morphology based algorithm. Coronal T2-weighted images of 17 patients were acquired in four breath-holds using the HASTE sequence on a 1.5 Tesla MRI unit. The segmentation results were compared to ground truth kidney masks obtained as a consensus of experts. Automatic active contour algorithm yielded an average 22% +/- 8.6% volume error. A recently developed method (Bridge Burner) based on thresholding and constrained morphology failed to separate PKD from the spleen, yielding 37.4% +/- 8.7% volume error. Manual post-editing reduced the volume error to 3.2% +/- 0.8% for active contours and 3.2% +/- 0.6% for Bridge Burner. The total time (automated algorithm plus editing) was 15 min +/- 5 min for active contours and 19 min +/- 11 min for Bridge Burner. The average volume errors for stereology method were 5.9%, 6.2%, 5.4% for mesh size 6.6, 11, 16.5 mm. The average processing times were 17, 7, 4 min. These results show that nearly two-fold improvement in PKD segmentation accuracy over stereology technique can be achieved with a combination of active contours and post-editing.